Vanguard Group’s eXoZymes Inc EXOZ Stock Holding History

Vanguard Group’s Portfolio EXOZ Stock Details EXOZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$344K	Buy	31,516 +5,535	+21%	+$76.3K	﹤0.01%	4015
2025 Q3	$383K	Buy	25,981 +2,827	+12%	+$30.8K	﹤0.01%	4007
2025 Q2	$222K	Sell	23,154 -27,216	-54%	-$332K	﹤0.01%	4074
2025 Q1	$526K	Sell	50,370 -90	-0.2%	-$1.34K	﹤0.01%	3874
2024 Q4	$833K	Buy	+50,460	New	+$745K	﹤0.01%	3820

Other funds holding EXOZ

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Vanguard Group's EXOZ Position: Q4 2025 in Review

Vanguard Group increased its eXoZymes Inc (EXOZ) stake by 21% in Q4 2025, buying an estimated $76.3K and bringing the position to 31,516 shares worth $344K. The position accounts for ﹤0.01% of the portfolio, ranked #4015.

Vanguard Group first reported a position in EXOZ in Q4 2024 and has held it in 5 quarters since. The position peaked at $833K in Q4 2024. 7 funds tracked by Wall St. Rank hold EXOZ as of Q4 2025.

Vanguard Group held 31,516 shares of eXoZymes Inc worth $344K as of Q4 2025.
Vanguard Group bought 5,535 eXoZymes Inc shares in Q4 2025, an estimated $76.3K.
eXoZymes Inc made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4015 holding.
Vanguard Group first reported a position in eXoZymes Inc in Q4 2024 and has held it in 5 quarters since.
Vanguard Group's eXoZymes Inc position peaked at $833K in Q4 2024.
7 funds tracked by Wall St. Rank held eXoZymes Inc as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.